Cytokinetics, Incorporated
IT ˙ BIT ˙ US23282W6057
62,32 € 0,00 (0,00%)
2026-06-05
DEL PRIS
SecurityIT:1CYTK / Cytokinetics, Incorporated
InstitutionCrossmark Global Holdings, Inc.
Latest Disclosed Ownership8,648 shares
Latest Disclosed Value $ 569,989
Crossmark Global Holdings, Inc. reports 5.95% increase in ownership of 1CYTK / Cytokinetics, Incorporated

On May 11, 2026 - Crossmark Global Holdings, Inc. filed a 13F-HR form disclosing ownership of 8,648 shares of Cytokinetics, Incorporated (IT:1CYTK) valued at $466,992 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 8,162 shares of Cytokinetics, Incorporated. This represents a change in shares of 5.95% during the quarter. The current value of the position is $538,943 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F CYTOKINETICS COM NEW 23282W605 8,648 486 5.95 570 9.85 0.0083
2026-02-03 2025-12-31 13F CYTOKINETICS COM NEW 23282W605 8,162 347 4.44 519 20.75 0.0074
2025-11-12 2025-09-30 13F CYTOKINETICS COM NEW 23282W605 7,815 60 0.77 430 67.58 0.0064
2025-08-08 2025-06-30 13F CYTOKINETICS COM NEW 23282W605 7,755 174 2.30 256 -15.79 0.0041
2025-04-30 2025-03-31 13F CYTOKINETICS COM NEW 23282W605 7,581 -46 -0.60 305 0.0054
2025-01-16 2024-12-31 13F CYTOKINETICS INC COM COM 23282W605 7,627 -13 -0.17 0 0.0065
2024-11-04 2024-09-30 13F CYTOKINETICS INC COM COM 23282W605 7,640 1,072 16.32 0 0.0072
2024-07-29 2024-06-30 13F CYTOKINETICS INC COM COM 23282W605 6,568 -8 -0.12 0 0.0068
2024-05-13 2024-03-31 13F CYTOKINETICS INC COM COM 23282W605 6,576 -890 -11.92 0 0.0088
2024-02-13 2023-12-31 13F CYTOKINETICS INC COM COM 23282W605 7,466 -603 -7.47 1 0.0129
2023-11-08 2023-09-30 13F CYTOKINETICS INC COM COM 23282W605 8,069 19 0.24 0 0.0064
2023-07-31 2023-06-30 13F CYTOKINETICS INC COM COM 23282W605 8,050 -39 -0.48 0 0.0058
2023-05-12 2023-03-31 13F CYTOKINETICS INC COM COM 23282W605 8,089 19 0.24 0 0.0067
2023-01-19 2022-12-31 13F CYTOKINETICS INC COM COM 23282W605 8,070 -120 -1.47 0 -100.00 0.0092
2022-11-01 2022-09-30 13F CYTOKINETICS INC COM COM 23282W605 8,190 490 6.36 397 31.46 0.0110
2022-07-29 2022-06-30 13F CYTOKINETICS INC COM COM 23282W605 7,700 -170 -2.16 302 4.14 0.0078
2022-05-11 2022-03-31 13F CYTOKINETICS INC COM COM 23282W605 7,870 20 0.25 290 -18.99 0.0065
2022-01-10 2021-12-31 13F CYTOKINETICS INC COM COM 23282W605 7,850 -8,200 -51.09 358 -37.63 0.0078
2021-10-21 2021-09-30 13F/A-1 CYTOKINETICS INC COM COM 23282W605 16,050 -30 -0.19 574 80.50 0.0134
2021-07-21 2021-06-30 13F CYTOKINETICS INC COM COM 23282W605 16,080 130 0.82 318 -14.29 0.0075
2021-04-15 2021-03-31 13F CYTOKINETICS INC COM COM 23282W605 15,950 610 3.98 371 16.30 0.0092
2021-01-14 2020-12-31 13F CYTOKINETICS INC COM COM 23282W605 15,340 15,340 319 0.0081
2018-02-05 2017-12-31 13F CYTOKINETICS INC COM COM 23282W605 0 -21,460 -100.00 0 -100.00
2017-10-27 2017-09-30 13F CYTOKINETICS INC COM COM 23282W605 21,460 0 0.00 311 0.00 0.0080
2017-10-25 2016-09-30 13F CYTOKINETICS INC COM COM 23282W605 21,460 21,460 311 0.0080
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.